Trademark applications and grants for Merrimack Pharmaceuticals Inc. Merrimack Pharmaceuticals Inc has 30 trademark applications. The latest application filed is for "M"
Patent Application | Date |
---|---|
ANTI-TNFR2 ANTIBODIES AND USES THEREOF 20220281990 - 17/434340 ZHOU; Yu ;   et al. | 2022-09-08 |
ANTI-TNFR2 ANTIBODIES AND USES THEREOF 20210371537 - 17/276686 TAM; Eric M. ;   et al. | 2021-12-02 |
Nanoliposomal Targeting of Ephrin Receptor A2 (Epha2) and Related Diagnostics 20190298681 - 16/085486 Drummond; Daryl C. ;   et al. | 2019-10-03 |
ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF 20190292271 - 16/181054 SCHOEBERL; Birgit M. ;   et al. | 2019-09-26 |
METHODS FOR SELECTING AND TREATING PATIENTS WITH A TRAIL-BASED THERAPEUTIC OR DEATH RECEPTOR AGONIST 20190185541 - 16/305289 DAKE; Tamara ;   et al. | 2019-06-20 |
NCAGE Code | 6ZU98 | MERRIMACK PHARMACEUTICALS, INC. |
CAGE Code | 6ZU98 | MERRIMACK PHARMACEUTICALS, INC. |
SEC | 0001274792 | MERRIMACK PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.